COVID-19 Vaccine VidPrevtyn Beta (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted]) 5micrograms/0.5ml dose solution and emulsion for emulsion for injection multidose vials (Sanofi)

COVID-19 Vaccine VidPrevtyn Beta (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted]) 5micrograms/0.5ml dose solution and emulsion for emulsion for injection multidose vials (Sanofi) (real clinical drug)

active
Code40872011000001104
Semantic tagreal clinical drug
Moduleuk-clinical
Definitiondefined
Effective time20260506

Parents (2)

Children (0)

None (leaf concept).